Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine

被引:63
|
作者
Swaminathan, GJ
Holloway, DE
Colvin, RA
Campanella, GK
Papageorgiou, AC
Luster, AD
Acharya, KR [1 ]
机构
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[2] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA 02129 USA
关键词
D O I
10.1016/S0969-2126(03)00070-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have determined the structure of wild-type IP-10 from three crystal forms. The crystals provide eight separate models of the IP-10 chain, all differing substantially from a monomeric IP-10 variant examined previously by NMR spectroscopy. In each crystal form, IP-10 chains form conventional beta sheet dimers, which, in turn, form a distinct tetrameric assembly. The M form tetramer is reminiscent of platelet factor 4, whereas the T and H forms feature a novel twelve-stranded beta sheet. Analytical ultracentrifugation indicates that, in free solution, IP-10 exists in a monomer-dimer equilibrium with a dissociation constant of 9 muM. We propose that the tetrameric structures may represent species promoted by the binding of glycosaminoglycans. The binding sites for several IP-10-neutralizing mAbs have also been mapped.
引用
收藏
页码:521 / 532
页数:12
相关论文
共 50 条
  • [41] Structure of mouse IP-10, a chemokine
    Jabeen, Talat
    Leonard, Philip
    Jamaluddin, Haryati
    Acharya, K. Ravi
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2008, 64 : 611 - 619
  • [42] Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection
    Cinque, P
    Bestetti, A
    Marenzi, R
    Sala, S
    Gisslen, M
    Hagberg, L
    Price, RW
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2005, 168 (1-2) : 154 - 163
  • [43] Differential activation of murine eosinophils by the CXCR3 ligands CXCL9 (MIG) and CXCL10 (IP-10)
    Thomas, MS
    Lukacs, NW
    [J]. FASEB JOURNAL, 2003, 17 (05): : A1357 - A1357
  • [44] IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
    Hayato Maruoka
    Daichi Inoue
    Yoko Takiuchi
    Seiji Nagano
    Hiroshi Arima
    Sumie Tabata
    Akiko Matsushita
    Takayuki Ishikawa
    Tatsuo Oita
    Takayuki Takahashi
    [J]. Annals of Hematology, 2014, 93 : 393 - 401
  • [45] IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome
    Maruoka, Hayato
    Inoue, Daichi
    Takiuchi, Yoko
    Nagano, Seiji
    Arima, Hiroshi
    Tabata, Sumie
    Matsushita, Akiko
    Ishikawa, Takayuki
    Oita, Tatsuo
    Takahashi, Takayuki
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (03) : 393 - 401
  • [46] MAP kinase regulation of IP10/CXCL10 chemokine gene expression in microglial cells
    Shen, Qin
    Zhang, Ran
    Bhat, Narayan R.
    [J]. BRAIN RESEARCH, 2006, 1086 : 9 - 16
  • [47] SIGNIFICANCE OF PLASMA IP-10 / CXCL10 LEVELS IN PATIENTS TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Takada, Hitomi
    Maekawa, Shinya
    Enomoto, Nobuyuki
    [J]. HEPATOLOGY, 2022, 76 : S1364 - S1364
  • [48] High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure
    Rotondi, M
    Rosati, A
    Buonamano, A
    Lasagni, L
    Lazzeri, E
    Pradella, F
    Fossombroni, V
    Cirami, C
    Liotta, F
    La Villa, G
    Serio, M
    Bertoni, E
    Salvadori, M
    Romagnani, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (09) : 1466 - 1474
  • [49] IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment
    Clark, Amanda M.
    Heusey, Haley L.
    Griffith, Linda G.
    Lauffenburger, Douglas. A.
    Wells, Alan
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] IP-10/CXCL10 expression is induced in tumor stroma in pancreatic cancer and correlates with poor survival in patients
    Lunardi, S.
    Jamieson, N. B.
    Griffiths, K. L.
    Carvalho-Gaspar, M. M.
    Lim, S. Y.
    Al-Assar, O.
    Carter, R. C.
    McKay, C. J.
    Silva, M. A.
    Janssen, K. -P.
    Muschel, R. J.
    Brunner, T. B.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 77 - 77